RAMIK - Overview: Amikacin, Random, Serum
Monitoring adequacy of blood concentration during amikacin therapy
ADULT - Overview: Adulterants Survey, Random, Urine
Assessment of possible adulteration of a urine specimen submitted for drug of abuse testing Providing the creatinine concentration for normalization purposes
PAMIK - Overview: Amikacin, Peak, Serum
Monitoring adequacy of serum concentration during amikacin therapy
TAMIK - Overview: Amikacin, Trough, Serum
Monitoring adequate clearance of amikacin near the end of a dosing cycle
HCO3 - Overview: Bicarbonate, Serum
Diagnosis and treatment of acid-base imbalance in respiratory and metabolic systems
BILID - Overview: Bilirubin Direct, Serum
Evaluation of jaundice and liver functions
RCTUR - Overview: Creatinine, Random, Urine
Calculation of creatinine clearance, a measure of renal function, when used in conjunction with serum creatinine Normalization of urinary analytes by creatinine concentration to account for the variation in urinary concentrations between...
CULAF - Overview: Culture for Genetic Testing, Amniotic Fluid
Producing amniocyte cultures that can be used for genetic analysis
DXPIN - Overview: Doxepin and Nordoxepin, Serum
Monitoring doxepin therapy Evaluating potential doxepin toxicity Evaluating patient compliance
DESPR - Overview: Desipramine, Serum
Monitoring serum concentration of desipramine during therapy Evaluating potential desipramine toxicity May aid in evaluating patient compliance
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...